Not Yet RecruitingNot applicableNCT07685028

LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol A

This research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals.

Checked against the public recordLast updated Jul 6, 2026 · Source: ClinicalTrials.gov

StatusNot Yet Recruiting
PhaseNot applicable
U.S. locations1
SponsorMassachusetts General Hospital
01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
Massachusetts General Hospital
Interventions being studied
Diagnostic Test: CT scan; Other: Sybil
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Age: Must meet both the upper and lower age limit criteria. * Upper age limit: ≤80 years of age * Lower age limit: * ≥40 years of age OR * ≥18 years of age AND ≤10 years of youngest relative's age at time of lung cancer diagnosis (e.g., if a relative was diagnosed at 35 years of age, participant can enroll at ≥25 years of age) * Positive family history of lung cancer (defined as): * Has ≥1 first-degree relative, OR * Has ≥2 second-degree relatives with a diagnosis of non-small cell lung cancer or small cell lung cancer (NB: a first-degree relative = parent, sibling, or child, a second-degree relative = grandparent, blood-related aunt or uncle, grandchild, blood-related niece or nephew, half-sibling) Exclusion Criteria: * Must not have a personal history of lung cancer at the time of enrollment. * Must not have a personal history of stage IV cancer of any type at the time of enrollment. * Must not have had surgical removal of any portion of the lung, excluding needle or core lung biopsy at the time of enrollment. * Must not have had a chest CT within 12 months prior to trial enrollment.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Massachusetts General HospitalBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 6, 2026. Always confirm current availability with the study team.

View original record ↗